Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 42.8B | 42.7B | 50.1B | 41.9B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 13.8B | 14.1B | 14.2B | 14.5B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 17.4B | 17.0B | 23.4B | 17.3B |
Tax provision | 3.4B | 4.1B | 5.3B | 3.9B |
Net income | 14.0B | 12.9B | 18.1B | 13.4B |
Basic EPS | — | 4.4 | 6.1 | 4.5 |
Diluted EPS | — | 4.4 | 6.1 | 4.4 |
Basic average shares | — | 2.9B | 2.9B | 2.9B |
Diluted average shares | — | 2.9B | 2.9B | 2.9B |
EBITDA | — | — | — | — |
Net income from continuing op. | 14.0B | 12.9B | 18.1B | 13.4B |
Minority interests | — | — | — | — |
Preferred stock dividends | 77M | 75M | 114M | 80M |